Anteris Technologies Enrolls First Patients in U.S. Heart Valve Trial
Anteris Technologies announced that the first patients in the United States have been enrolled and successfully treated in the DurAVR Transcatheter Heart Valve global pivotal trial for patients with severe calcific aortic stenosis. The procedures were performed by Azeem Latib, M.D. at Montefiore Medical Center, New York, United States.
